Dr Lindsay Hall is the Microbiome Research Leader at the Quadram Institute (www.quadram.ac.uk). Lindsay is also an Honorary Senior Lecturer at the Norwich Medical School at UEA.
Dr Hall qualified with a BSc (Hons) in Microbiology from the University of Glasgow in 2003. She went on to study for a PhD in Microbiology and Immunology at the Wellcome Trust Sanger Institute under the supervision of Prof Gordon Dougan (FRS). In 2007 Lindsay took up a postdoctoral position at the APC Microbiome Institute, University College Cork in Ireland, after which she returned to the UK in 2011 to take up a lecturing and Principle Investigator position within the Norwich Medical School, UEA.
In 2013 Lindsay was awarded a 5 year Wellcome Trust New Investigator Award and in 2014 was promoted to senior lecturer in Gastrointestinal Sciences. In November 2015 she moved to the Quadram Institute and she also currently holds an honorary position at UEA. See www.halllab.co.uk for more details.
Career History
2015 - Current: Microbiome Research Leader, Quadram Institute, Norwich Research Park, Norwich.
2015 - Current: Honorary Senior Lecturer, Norwich Medical School, Unoversity of East Anglia, Norwich Research Park, Norwich
2014 - 2015: Senior Lecturer and Research Leader in Gastrointestinal Sciences, Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich.
2011 - Current: Research Leader, Institute of Food Research, Norwich Research Park, Norwich.
2011 - 2014: Lecturer and Research Leader in Gastrointestinal Sciences, Norwich Medical School, University East Anglia, Norwich Research Park, Norwich.
2007 - 2011: Post Doctoral Research Fellow, Alimentary Pharmabiotic Centre, Biosciences Institute, University College Cork, Cork, Ireland.
2003 - 2007: Ph.D, University of Cambridge. The Wellcome Trust Sanger Institute, Hinxton, Cambridge.
1999 – 2003: BSc (Hons), Microbiology, University of Glasgow.
Key publications
Hughes KR, Harnisch L, Alcon-Giner C, Mitra S, Wright CJ, Ketskemety J, van Sinderen D, Watson AJM, and Hall LJ. Bifidobacterium breve reduces apoptotic epithelial cell shedding in an exopolysaccharide and MyD88-dependent manner. Open Biology. 2017. DOI: 10.1098/rsob.160155
Hall LJ, Murphy CT, Quinlan A, Hurley G, Shanahan F, Nally K, Melgar S. Natural killer cells protect mice from DSS-induced colitis by regulating neutrophil function via the NKG2A receptor. Mucosal Immunol. 2013;6(5):1016-26
Hall LJ, Murphy CT, Quinlan A, Hurley G, Shanahan F, Nally K, Melgar S. Natural Killer cells protect against mucosal and systemic infection with the enteric pathogen Citrobacter rodentium. Infect. Immun. 2013;81(2):460-9
Hall LJ/Fanning S, Cronin M, Zomer A, MacSharry J, Goulding D, O’Connell-Motherway M, Shanahan F, Nally K, Dougan G, van Sinderen D. Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation & pathogen protection. Proc Natl Acad Sci U S A. 2012 Feb 7;109(6):2108-13.
Hall LJ/ Jansen AM, , Clare S, Goulding D, Holt KE, Grant AJ, Mastroeni P, Dougan G, Kingsley RA. A Salmonella Typhimurium-Typhi genomic chimera: A murine-typhoid model to study Vi polysaccharide capsule function. PLoS Pathogens. 2011 Jul;7(7):e1002131.